StockData
Dare Bioscience, Inc. logo

Dare Bioscience, Inc. (DARE) stock

DARENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$0.43−0.16 (-26.57%)

Close on Nov 17, 2026Market cap $6.56MP/E –Yield –

Dare Bioscience total assets

Total assets on the balance sheet at the end of each period.

Dare Bioscience's total assets was $22.37M at Jun 30, 2026. For fiscal 2025 it was $32.47M, up 46.9% from the year before. Over ten years it grew -8.4% a year on average. The highest annual figure on record is $78.23M in fiscal 2015.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$32.47M+46.9%
FY2024Dec 31, 2024$22.10M+3.8%
FY2023Dec 31, 2023$21.28M-51.4%
FY2022Dec 31, 2022$43.83M-21.5%
FY2021Dec 31, 2021$55.81M+639.1%
FY2020Dec 31, 2020$7.55M+1.5%
FY2019Dec 31, 2019$7.44M-4.9%
FY2018Dec 31, 2018$7.83M-45.1%
FY2017Dec 31, 2017$14.26M+31862.7%
FY2016Dec 31, 2016$44.61K-99.9%
FY2015Dec 31, 2015$78.23M+46.5%
FY2014Dec 31, 2014$53.39M+682.1%
FY2013Dec 31, 2013$6.83M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$22.37M+72.3%
Q1 FY2026Mar 31, 2026$27.83M+49.5%
Q4 FY2025Dec 31, 2025$32.47M+46.9%
Q3 FY2025Sep 30, 2025$30.75M+70.3%
Q2 FY2025Jun 30, 2025$12.98M-45.0%
Q1 FY2025Mar 31, 2025$18.62M+43.1%
Q4 FY2024Dec 31, 2024$22.10M+3.8%
Q3 FY2024Sep 30, 2024$18.06M-27.9%
Q2 FY2024Jun 30, 2024$23.61M+1.7%
Q1 FY2024Mar 31, 2024$13.01M-57.1%
Q4 FY2023Dec 31, 2023$21.28M-51.4%
Q3 FY2023Sep 30, 2023$25.05M-50.3%
Q2 FY2023Jun 30, 2023$23.21M-54.8%
Q1 FY2023Mar 31, 2023$30.37M-38.3%
Q4 FY2022Dec 31, 2022$43.83M-21.5%
Q3 FY2022Sep 30, 2022$50.38M+3.2%
Q2 FY2022Jun 30, 2022$51.39M+246.7%
Q1 FY2022Mar 31, 2022$49.19M+367.6%
Q4 FY2021Dec 31, 2021$55.81M+639.1%
Q3 FY2021Sep 30, 2021$48.81M+537.1%
Q2 FY2021Jun 30, 2021$14.82M+72.9%
Q1 FY2021Mar 31, 2021$10.52M+3.0%
Q4 FY2020Dec 31, 2020$7.55M+1.5%
Q3 FY2020Sep 30, 2020$7.66M+97.4%
Q2 FY2020Jun 30, 2020$8.57M+18.0%
Q1 FY2020Mar 31, 2020$10.21M+103.5%
Q4 FY2019Dec 31, 2019$7.44M-4.9%
Q3 FY2019Sep 30, 2019$3.88M-64.0%
Q2 FY2019Jun 30, 2019$7.26M-46.1%
Q1 FY2019Mar 31, 2019$5.02M-69.8%
Q4 FY2018Dec 31, 2018$7.83M-45.1%
Q3 FY2018Sep 30, 2018$10.80M-53.6%
Q2 FY2018Jun 30, 2018$13.48M+65.4%
Q1 FY2018Mar 31, 2018$16.63M+4.2%
Q4 FY2017Dec 31, 2017$14.26M+31862.7%
Q3 FY2017Sep 30, 2017$23.27M-42.0%
Q2 FY2017Jun 30, 2017$8.15M–
Q1 FY2017Mar 31, 2017$15.95M–
Q4 FY2016Dec 31, 2016$44.61K–
Q3 FY2016Sep 30, 2016$40.13M–

More Dare Bioscience figures

See a number that looks wrong?